{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:49Z","timestamp":1783468849922,"version":"3.55.0"},"reference-count":27,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:00:00Z","timestamp":1614902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Introduction: One of the main factors contributing to the development of nutritional deficits in chronic heart failure (CHF) patients is the systemic inflammatory process. Progressing inflammatory response leads to exacerbation of the disease and could develop into cardiac cachexia (CC), characterized by involuntary weight loss followed by muscle wasting. The aim of this study was to assess the relationship between rs767455 (36 T\/C) of the TNFRSF1A and the occurrence of nutritional disorders in CHF patients with cachexia. Materials and Methods: We enrolled 142 CHF individuals who underwent cardiac and nutritional screening in order to assess cardiac performance and nutritional status. The relationship between TNFRSF1A rs767455 genotypes and patients\u2019 features was investigated. Results: A greater distribution of the TT genotype among cachectic patients in contrast to non-cachectic individuals was found (TT frequencies of 62.9% and 37.1%, respectively; p = 0.013). We noted a significantly lower albumin concentration (p = 0.039) and higher C-reactive protein (CRP) levels (p = 0.019) in patients with the TT genotype. Regarding cardiac parameters, CHF individuals bearing the TT genotype demonstrated a significant reduction in ejection fraction (EF) (p = 0.033) in contrast to other genotype carriers; moreover, they had a significantly higher concentration of N-terminal prohormone of brain natriuretic peptide (NT-proBNP) in the blood (p = 0.018). We also noted a lower frequency of TT genotype carriers among individuals qualified as grades I or II of the New York Heart Association (NYHA) (p = 0.006). The multivariable analysis selected the TT genotype as an unfavorable factor related to a higher chance of cachexia in CHF patients (Odds ratio (OR) = 2.56; p = 0.036). Conclusions: The rs767455TT genotype of TNFRSF1A can be considered as an unfavorable factor related to a higher risk of cachexia in CHF patients.<\/jats:p>","DOI":"10.3390\/jcm10051095","type":"journal-article","created":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T11:46:09Z","timestamp":1614944769000},"page":"1095","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical Significance of TNFRSF1A36T\/C Polymorphism in Cachectic Patients with Chronic Heart Failure"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1950-2804","authenticated-orcid":false,"given":"Grzegorz","family":"Sobieszek","sequence":"first","affiliation":[{"name":"Department of Cardiology, 1st Military Clinical Hospital with the Outpatient Clinic, 20-080 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Powr\u00f3zek","sequence":"additional","affiliation":[{"name":"Department of Human Physiology, Medical University of Lublin, 20-059 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneta","family":"Skwarek-Dziekanowska","sequence":"additional","affiliation":[{"name":"Department of Cardiology, 1st Military Clinical Hospital with the Outpatient Clinic, 20-080 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3384-0324","authenticated-orcid":false,"given":"Teresa","family":"Ma\u0142ecka-Massalska","sequence":"additional","affiliation":[{"name":"Department of Human Physiology, Medical University of Lublin, 20-059 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,3,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.3389\/fimmu.2019.02315","article-title":"Immunity, Inflammation and Heart Failure: Their Role on Cardiac Function and Iron Status","volume":"10","author":"Perticone","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Sobieszek, G., Powr\u00f3zek, T., Mazurek, M., Skwarek-Dziekanowska, A., and Ma\u0142ecka-Massalska, T. (2020). Electrical and Hormonal Bi-omarkers in Cachectic Elderly Women with Chronic Heart Failure. J. Clin. Med., 9.","DOI":"10.3390\/jcm9041021"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4065\/mcp.2009.0494","article-title":"Chronic Heart Failure: Contemporary Diagnosis and Management","volume":"85","author":"Ramani","year":"2010","journal-title":"Mayo Clin. Proc."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1536\/ihj.16-236","article-title":"TNF Receptor 1\/2 Predict Heart Failure Risk in Type 2 Diabetes Mellitus Patients","volume":"58","author":"Ping","year":"2017","journal-title":"Int. Heart J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"H1288","DOI":"10.1152\/ajpheart.00526.2001","article-title":"TNF-alpha and myocardial matrix metallo-proteinases in heart failure: Relationship to LV remodeling","volume":"282","author":"Bradham","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.hfc.2009.04.001","article-title":"Inflammatory biomarkers in heart failure revisited: Much more than innocent bystanders","volume":"5","author":"Schefold","year":"2009","journal-title":"Heart Fail. Clin."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08820139.2019.1708384","article-title":"Genetic Variation on TNF\/LTA and TNFRSF1A Genes is Associated with Outcomes of Hepatitis C Virus Infection","volume":"50","author":"Yue","year":"2021","journal-title":"Immunol. Investig."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e000246","DOI":"10.1136\/bmjgast-2018-000246","article-title":"Genetic polymorphisms in tumour necrosis factor receptors (TNFRSF1A\/1B) illustrate dif-ferential treatment response to TNF\u03b1 inhibitors in patients with Crohn\u2019s disease","volume":"6","author":"Qasem","year":"2019","journal-title":"BMJ Open Gastroenterol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: A new definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clin. Nutr."},{"key":"ref_10","unstructured":"Gaetano, J. (2021, February 15). Holm-Bonferroni Sequential Correction: An EXCEL Calculator (1.2) [Microsoft Excel Workbook]. Available online: https:\/\/www.researchgate.net\/publication\/242331583_Holm-Bonferroni_Sequential_Correction_An_EXCEL_Calculator_-_Ver._1.2."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/MAJ.0000000000000511","article-title":"Mechanisms of Cachexia in Chronic Disease States","volume":"350","author":"Yoshida","year":"2015","journal-title":"Am. J. Med Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/BOR.0000000000000572","article-title":"Gene-function studies in systemic lupus erythematosus","volume":"31","author":"Rosetti","year":"2019","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1468-3083.2010.03776.x","article-title":"Association of ITGAM polymorphism with systemic lupus erythematosus: A meta-analysis","volume":"25","author":"Fan","year":"2011","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1161\/01.RES.0000043825.01705.1B","article-title":"Inflammatory mediators and the failing heart: Past, present, and the foreseeable future","volume":"91","author":"Mann","year":"2002","journal-title":"Circ. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1161\/01.CIR.0000085203.46621.F4","article-title":"Targeted Overexpression of Transmembrane Tumor Necrosis Factor Provokes a Concentric Cardiac Hypertrophic Phenotype","volume":"108","author":"Dibbs","year":"2003","journal-title":"Circulation"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1161\/01.CIR.0000109642.27985.FA","article-title":"Targeted overexpression of non-cleavable and secreted forms of tumor necrosis factor provokes disparate cardiac phenotypes","volume":"109","author":"Diwan","year":"2004","journal-title":"Circulation"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1161\/01.CIR.102.14.1690","article-title":"Cardiac-Specific Overexpression of Tumor Necrosis Factor-\u03b1 Causes Oxidative Stress and Contractile Dysfunction in Mouse Diaphragm","volume":"102","author":"Li","year":"2000","journal-title":"Circulation"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1161\/01.RES.81.4.627","article-title":"Dilated cardiomy-opathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha","volume":"81","author":"Kubota","year":"1997","journal-title":"Circ. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1160\/TH06-06-0314","article-title":"Polymorphism A36G of the tumor necrosis factor receptor 1 gene is associated with PAI-1 levels in obese women","volume":"97","author":"Mavri","year":"2007","journal-title":"Thromb. Haemost."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Cho, J.Y., Kim, K.H., Cho, H.-J., Lee, H.-Y., Choi, J.-O., Jeon, E.-S., Lee, S.E., Kim, M.-S., Kim, J.-J., and Hwang, K.-K. (2018). Nutritional risk index as a predictor of mortality in acutely decompensated heart failure. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0209088"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1079\/BJN20041292","article-title":"Bioelectrical impedance phase angle as a prognostic indicator in advanced pancreatic cancer","volume":"92","author":"Gupta","year":"2004","journal-title":"Br. J. Nutr."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/ajcn\/80.6.1634","article-title":"Bioelectrical impedance phase angle in clinical practice: Implications for prognosis in advanced colorectal cancer","volume":"80","author":"Gupta","year":"2004","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Gupta, D., Lammersfeld, C.A., Vashi, P.G., King, J., Dahlk, S.L., Grutsch, J.F., and Lis, C.G. (2008). Bioelectrical impedance phase angle as a prognostic indicator in breast cancer. BMC Cancer, 8.","DOI":"10.1186\/1471-2407-8-249"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1002\/cncr.28624","article-title":"Phase angle for prognostication of survival in patients with advanced cancer: Preliminary findings","volume":"120","author":"Hui","year":"2014","journal-title":"Cancer"},{"key":"ref_25","first-page":"509","article-title":"Norms and correlates of bioimpedance phase angle in healthy human subjects, hospitalized patients, and patients with liver cirrhosis","volume":"86","author":"Selberg","year":"2002","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/ajcn\/72.2.496","article-title":"Phase angle from bioelectrical impedance analysis remains an independent predictive marker in HIV-infected patients in the era of highly active antiretroviral treatment","volume":"72","author":"Schwenk","year":"2000","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.12740\/PP\/67500","article-title":"Application of phase angle for evaluation of the nutrition status of patients with anorexia nervosa","volume":"51","author":"Teter","year":"2017","journal-title":"Psychiatr. Pol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/5\/1095\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:33:45Z","timestamp":1760160825000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/5\/1095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,5]]},"references-count":27,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,3]]}},"alternative-id":["jcm10051095"],"URL":"https:\/\/doi.org\/10.3390\/jcm10051095","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,5]]}}}